Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:125 |
|---|---|
| Enthalten in: |
Biochemical pharmacology - 125(2017), Seite 55-74 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Maucher, Isabelle V [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1016/j.bcp.2016.11.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC199067836X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC199067836X | ||
| 003 | DE-627 | ||
| 005 | 20230715032422.0 | ||
| 007 | tu | ||
| 008 | 170303s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bcp.2016.11.004 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC199067836X | ||
| 035 | |a (DE-599)GBVOLC199067836X | ||
| 035 | |a (PRQ)c660-fe69d7a064270d082337d4168f9ea5ec8a5197207826bfe9c4d3d7ae2d5560d90 | ||
| 035 | |a (KEY)0068825820170000125000000055michaelacceptorcontainingdrugsareanovelclassof5lip | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Maucher, Isabelle V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Rühl, Michael |4 oth | |
| 700 | 1 | |a Kretschmer, Simon B.M |4 oth | |
| 700 | 1 | |a Hofmann, Bettina |4 oth | |
| 700 | 1 | |a Kühn, Benjamin |4 oth | |
| 700 | 1 | |a Fettel, Jasmin |4 oth | |
| 700 | 1 | |a Vogel, Anja |4 oth | |
| 700 | 1 | |a Flügel, Karsten T |4 oth | |
| 700 | 1 | |a Manolikakes, Georg |4 oth | |
| 700 | 1 | |a Hellmuth, Nadine |4 oth | |
| 700 | 1 | |a Häfner, Ann-Kathrin |4 oth | |
| 700 | 1 | |a Golghalyani, Vahid |4 oth | |
| 700 | 1 | |a Ball, Ann-Katrin |4 oth | |
| 700 | 1 | |a Piesche, Matthias |4 oth | |
| 700 | 1 | |a Matrone, Carmela |4 oth | |
| 700 | 1 | |a Geisslinger, Gerd |4 oth | |
| 700 | 1 | |a Parnham, Michael J |4 oth | |
| 700 | 1 | |a Karas, Michael |4 oth | |
| 700 | 1 | |a Steinhilber, Dieter |4 oth | |
| 700 | 1 | |a Roos, Jessica |4 oth | |
| 700 | 1 | |a Maier, Thorsten J |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical pharmacology |d New York, NY : Elsevier, 1958 |g 125(2017), Seite 55-74 |w (DE-627)12950355X |w (DE-600)208787-X |w (DE-576)014906775 |x 0006-2952 |7 nnns |
| 773 | 1 | 8 | |g volume:125 |g year:2017 |g pages:55-74 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.bcp.2016.11.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 125 |j 2017 |h 55-74 | ||